Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duvivier

Showing results (361-370 of 505) with videos related to

Pageof 51
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2018
Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4)Dominique Costagliola, Valérie Potard, Sylvie Lang, et al.
AIDS (London, England)|March 22, 2008
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individualsBrian Angus, Fiona Lampe, Guiseppe Tambussi, et al.
Journal of Medical Virology|September 21, 2005
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097)Constance Delaugerre, Gilles Peytavin, Stephanie Dominguez, et al.
Antiviral Therapy|February 6, 2004
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individualsClaudine Duvivier, Astriti Myrto, Anne-Geneviève Marcelin, et al.
Plos One|August 17, 2017
Detectable HIV-RNA in semen of HIV controllersMarie-Laure Chaix, Faroudy Boufassa, Candice Meyzer, et al.
HIV Medicine|June 3, 2009
A large French prospective cohort of HIV-infected patients: the Nadis CohortPascal Pugliese, Lise Cuzin, André Cabié, et al.
Antiviral Therapy|August 20, 2003
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial)Constance Delaugerre, Karine Gourlain, Roland Tubiana, et al.
Public Health|June 30, 2021
Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohortA Le Guillou, A Cabie, C Delpierre, et al.
Journal of Perinatal Medicine|April 28, 2026
Maternal vaccination in the immunization era: implementation, uptake, and emerging vaccinesAntônio Braga, Susana Cristina Aidé Viviani Fialho, Caroline Alves de Oliveira Martins, et al.
Frontiers in Immunology|October 11, 2017
Potential Role of Vδ2<sup>+</sup> γδ T Cells in Regulation of Immune Activation in Primary HIV InfectionNupur Bhatnagar, Pierre-Marie Girard, Moises Lopez-Gonzalez, et al.
Pageof 51

Showing results (361-370 of 505) with videos related to

Sort By:
Pageof 51
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2018
Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4)Dominique Costagliola, Valérie Potard, Sylvie Lang, et al.
AIDS (London, England)|March 22, 2008
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individualsBrian Angus, Fiona Lampe, Guiseppe Tambussi, et al.
Journal of Medical Virology|September 21, 2005
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097)Constance Delaugerre, Gilles Peytavin, Stephanie Dominguez, et al.
Antiviral Therapy|February 6, 2004
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individualsClaudine Duvivier, Astriti Myrto, Anne-Geneviève Marcelin, et al.
Plos One|August 17, 2017
Detectable HIV-RNA in semen of HIV controllersMarie-Laure Chaix, Faroudy Boufassa, Candice Meyzer, et al.
HIV Medicine|June 3, 2009
A large French prospective cohort of HIV-infected patients: the Nadis CohortPascal Pugliese, Lise Cuzin, André Cabié, et al.
Antiviral Therapy|August 20, 2003
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial)Constance Delaugerre, Karine Gourlain, Roland Tubiana, et al.
Public Health|June 30, 2021
Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohortA Le Guillou, A Cabie, C Delpierre, et al.
Journal of Perinatal Medicine|April 28, 2026
Maternal vaccination in the immunization era: implementation, uptake, and emerging vaccinesAntônio Braga, Susana Cristina Aidé Viviani Fialho, Caroline Alves de Oliveira Martins, et al.
Frontiers in Immunology|October 11, 2017
Potential Role of Vδ2<sup>+</sup> γδ T Cells in Regulation of Immune Activation in Primary HIV InfectionNupur Bhatnagar, Pierre-Marie Girard, Moises Lopez-Gonzalez, et al.
Pageof 51